Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1714.00 | 1633.25 | 1.0494 | 1.0985 | |
SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1245.00 | 1633.25 | 0.7623 | 0.5263 | |
SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1418.00 | 1633.25 | 0.8682 | 0.7374 | |
SK-BR-3 | PLX-4720 | 19.9526 | uM | 4 | 1250.00 | 814.29 | 1610.00 | 1633.25 | 0.9858 | 0.9717 |
SK-BR-3 | Nilotinib | 3.1623 | uM | 4 | 1250.00 | 814.29 | 1474.00 | 1633.25 | 0.9025 | 0.8058 |
SK-BR-3 | Etoposide | 0.0033113 | uM | 4 | 1250.00 | 814.29 | 1702.00 | 1633.25 | 1.0421 | 1.0838 |
SK-BR-3 | Etoposide | 0.031623 | uM | 4 | 1250.00 | 814.29 | 1603.00 | 1633.25 | 0.9815 | 0.9631 |
SK-BR-3 | PLX-4720 | 0.031623 | uM | 4 | 1250.00 | 814.29 | 1491.00 | 1633.25 | 0.9129 | 0.8265 |
SK-BR-3 | Nilotinib | 0.31623 | uM | 4 | 1250.00 | 814.29 | 1680.00 | 1633.25 | 1.0286 | 1.0570 |
SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 4 | 1250.00 | 814.29 | 1794.00 | 1633.25 | 1.0984 | 1.1960 |
SK-BR-3 | PLX-4720 | 0.1 | uM | 4 | 1250.00 | 814.29 | 1578.00 | 1633.25 | 0.9662 | 0.9326 |
SK-BR-3 | NVP-TAE684 | 0.1 | uM | 4 | 1250.00 | 814.29 | 1618.00 | 1633.25 | 0.9907 | 0.9814 |
SK-BR-3 | NVP-TAE684 | 0.01 | uM | 4 | 1250.00 | 814.29 | 1710.00 | 1633.25 | 1.0470 | 1.0936 |
SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 2034.00 | 1633.25 | 1.2454 | 1.4885 | |
SK-BR-3 | Nilotinib | 0.01 | uM | 4 | 1250.00 | 814.29 | 1796.00 | 1633.25 | 1.0996 | 1.1984 |
SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1791.00 | 1633.25 | 1.0966 | 1.1923 | |
SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 4 | 1250.00 | 814.29 | 1873.00 | 1633.25 | 1.1468 | 1.2923 |
SK-BR-3 | Etoposide | 0.01 | uM | 4 | 1250.00 | 814.29 | 1650.00 | 1633.25 | 1.0103 | 1.0204 |
SK-BR-3 | Etoposide | 1 | uM | 4 | 1250.00 | 814.29 | 885.00 | 1633.25 | 0.5419 | 0.0865 |
SK-BR-3 | PLX-4720 | 10 | uM | 4 | 1250.00 | 814.29 | 1607.00 | 1633.25 | 0.9839 | 0.9680 |
SK-BR-3 | Etoposide | 10 | uM | 4 | 1250.00 | 814.29 | 523.00 | 1633.25 | 0.3202 | -0.3566 |
SK-BR-3 | Nilotinib | 0.0033113 | uM | 4 | 1250.00 | 814.29 | 1656.00 | 1633.25 | 1.0139 | 1.0277 |
SK-BR-3 | PLX-4720 | 0.01 | uM | 4 | 1250.00 | 814.29 | 1486.00 | 1633.25 | 0.9098 | 0.8204 |
SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1744.00 | 1633.25 | 1.0678 | 1.1350 | |
SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1430.00 | 1633.25 | 0.8756 | 0.7521 |